Purified ICAM-2 and fragment thereof
AssigneeDana-Farber Cancer Institute, Inc.
InventorsTimothy A. Springer, Donald E. Staunton, Michael L. Dustin
Life of this patent
Estimating the term…
Abstract
The present invention relates to intercellular adhesion molecules (ICAM-2) which are involved in the process through which lymphocytes recognize and migrate to sites of inflammation as well as attach to cellular substrates during inflammation. The invention is directed toward such molecules, screening assays for identifying such molecules and antibodies capable of binding such molecules. The invention also includes uses for adhesion molecules and for the antibodies that are capable of binding them.
Claims2
Purified human ICAM-2, wherein said human ICAM-2 consists of the amino acid sequence depicted in FIG. 2 which has two IG-like domains, binds LFA-1, and is not induced by cytokines.
Dependencies are inferred from the claim text.